down arrow

Alembic Pharma

28
Strong Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
840.00
1.5 (0.18%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
6,228.00
5,652.00
5,305.00
5,393.00
4,605.00
3,934.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6,228.00
5,652.00
5,305.00
5,393.00
4,605.00
3,934.00
Expenditure (Ex Depriciation)
Stock Adjustments
-142.00
78.00
-43.00
-193.00
-210.00
-92.00
Raw Materials Consumed
1,857.00
1,630.00
1,489.00
1,451.00
1,249.00
1,084.00
Power & Fuel Cost
173.00
151.00
120.00
118.00
102.00
88.00
Employee Cost
1,446.00
1,169.00
1,133.00
1,051.00
906.00
746.00
Operating Expenses
366.00
380.00
328.00
346.00
325.00
238.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
996.00
952.00
890.00
696.00
531.00
590.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
50.00
60.00
47.00
-44.00
95.00
32.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5,295.00
4,944.00
4,431.00
3,835.00
3,382.00
3,061.00
Operating Profit (PBDIT) excl Other Income
933.00
708.00
874.00
1,557.00
1,223.00
873.00
Other Income
28.00
2.00
50.00
10.00
4.00
9.00
Operating Profit (PBDIT)
961.00
711.00
924.00
1,567.00
1,227.00
882.00
Interest
56.00
50.00
17.00
16.00
27.00
18.00
Profit before Depriciation and Tax
905.00
660.00
906.00
1,551.00
1,200.00
864.00
Depreciation
272.00
275.00
286.00
183.00
157.00
115.00
Profit Before Taxation & Exceptional Items
632.00
385.00
620.00
1,368.00
1,043.00
749.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
631.00
354.00
625.00
1,368.00
999.00
749.00
Provision for Tax
16.00
12.00
104.00
253.00
199.00
156.00
Profit After Tax
616.00
372.00
515.00
1,114.00
800.00
592.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
3,568.00
2,554.00
2,384.00
1,538.00
1,286.00
937.00
Profit Available for appropriations
4,184.00
2,896.00
2,905.00
2,716.00
2,115.00
1,521.00
Appropriations
4,184.00
2,896.00
2,905.00
2,716.00
2,115.00
1,521.00
Equity Dividend (%)
550.00%
400.00%
500.00%
700.00%
500.00%
275.00%
Earnings Per Share
31.33
17.40
26.50
60.81
43.97
31.00
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 10.19% vs 6.54% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 31.76% vs -18.97% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 12.00% vs 182.97% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 65.40% vs -27.68% in Mar 2023

Compare Profit and Loss Results of Alembic Pharma
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,228.00
10,334.00
-4,106.00
-39.73%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,228.00
10,334.00
-4,106.00
-39.73%
Expenditure (Ex Depriciation)
Stock Adjustments
-142.00
-94.00
-48.00
-51.06%
Raw Materials Consumed
1,857.00
3,263.00
-1,406.00
-43.09%
Power & Fuel Cost
173.00
129.00
44.00
34.11%
Employee Cost
1,446.00
2,274.00
-828.00
-36.41%
Operating Expenses
366.00
210.00
156.00
74.29%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
996.00
928.00
68.00
7.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
50.00
134.00
-84.00
-62.69%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,295.00
7,798.00
-2,503.00
-32.10%
Operating Profit (PBDIT) excl Other Income
933.00
2,536.00
-1,603.00
-63.21%
Other Income
28.00
280.00
-252.00
-90.00%
Operating Profit (PBDIT)
961.00
2,817.00
-1,856.00
-65.89%
Interest
56.00
35.00
21.00
60.00%
Profit before Depriciation and Tax
905.00
2,782.00
-1,877.00
-67.47%
Depreciation
272.00
398.00
-126.00
-31.66%
Profit Before Taxation & Exceptional Items
632.00
2,384.00
-1,752.00
-73.49%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
631.00
2,399.00
-1,768.00
-73.70%
Provision for Tax
16.00
457.00
-441.00
-96.50%
Profit After Tax
616.00
1,926.00
-1,310.00
-68.02%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,568.00
8,012.00
-4,444.00
-55.47%
Profit Available for appropriations
4,184.00
9,925.00
-5,741.00
-57.84%
Appropriations
4,184.00
9,925.00
-5,741.00
-57.84%
Equity Dividend (%)
550%
0%
550.00
Earnings Per Share
31.33
47.75
-16.42
-34.39%
Profit And Loss - Net Sales
Net Sales 6,228.63 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 10.19% vs 6.54% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 933.36 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 31.76% vs -18.97% in Mar 2023

Profit And Loss - Interest
Interest 56.19 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 12.00% vs 182.97% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 616.79 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 65.40% vs -27.68% in Mar 2023